Donor Type, in Addition to Transplantation in Chronic Phase and Myeloablative Conditioning, Influence Transplant Survival for Patients with Advanced Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors

P Kongtim,K Adekola,D R Milton,R Ramlal,A Jimenez, J Chen,G Rondon,S Ahmed,P Kebriaei, O Betul,C M Hosing,U Popat,I Khouri,E Jabbour,J E Cortes,H M Kantarjian,R E Champlin,S O Ciurea

Leukemia（2017）

Cited 6|Views2

Key words

Haematological cancer,Myeloproliferative disease,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined